Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 3Unknown 2Not yet recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 15Thoracic 8Breast 3Gynecologic 2Genitourinary 2Sarcoma 1Other solid neoplasm 1

Conditions

Locally Advanced Cervical Carcinoma 1Gynecologic Cancers 1

Interventions

Paclitaxel 24Carboplatin 18Bevacizumab 14Cisplatin 12pembrolizumab 7fluzoparib 7Drug Therapy 7Radiotherapy 6camrelizumab 5apatinib 5Topotecan 5Magnetic Resonance Spectroscopy 5Injections 5liposomal doxorubicin 4lenvatinib 4famitinib 4Tirzepatide 4Specimen Handling 4Platinum 4Observation 4Gemcitabine 4Brachytherapy 4toripalimab 3olaparib 3dostarlimab 3anlotinib 3Watchful Waiting 3Therapeutics 3Surveys and Questionnaires 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Immunotherapy × Gynecologic × Clear all
NCT07613567 2026-05-29

A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer

Fujian Cancer Hospital

Phase 3 Not yet recruiting
486 enrolled
Gynecologic

Locally Advanced Cervical Carcinoma

NCT06945601 2025-04-25

FECONDE

IRCCS San Raffaele

Not yet recruiting
150 enrolled
Gynecologic

Gynecologic Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡